The FDA has received 8,753 adverse event reports for cats that name Nitenpyram.
- 8,753 reports name Nitenpyram in cats, which is 5.8% of all 151,164 cat reports. A report counts under every active ingredient it names.
- 11% are marked serious and 4.9% record a death or euthanasia; across all cat reports those figures are 27% and 9.4%.
- 27% are complaints that the product did not work (19% across all cat reports).
- The clinical signs reported most are hyperactivity, lack of efficacy (ectoparasite) - flea and panting.
- The FDA lists 2 approved animal drug applications containing Nitenpyram for cats, the earliest approved in 2000.
- None of this is a rate. The FDA data does not record how many cats were given Nitenpyram, so it cannot say how often any of this happens.
How the reports break down
| What the reports say | Reports | Share of this medicine's reports | All cat reports |
|---|---|---|---|
| Marked seriousthe FDA record flags the report as serious | 945 | 11% | 27% |
| Death or euthanasiathe outcome recorded in the report, with no finding of cause | 432 | 4.9% | 9.4% |
| Did not worka complaint that the product failed to work, which the FDA files as an adverse event | 2,403 | 27% | 19% |
| Seizurea seizure or convulsion is among the clinical signs | 186 | 2.1% | 2.6% |
| Not used per labelthe report says the product was not used the way its label directs | 1,066 | 12% | 33% |
Where on the body do the reported signs sit?
Not on the body: Did not work 16% Whole body 7.1%
- Behaviour41%hyperactivity, vocalisation, agitation, behavioural disorder and 5 more
- Did not work16%lack of efficacy (ectoparasite) - flea, lack of efficacy (flea)
- Heart and breathing14%panting, polypnoea
- Skin and coat11%scratching, pruritus, itching
- Stomach and gut8.9%vomiting, anorexia, diarrhoea, not eating and 1 more
- Whole body7.1%lethargy, death, fever
- Eyes1.6%dilated pupils
Each figure is a share of sign mentions among the 25 signs reported most for Nitenpyram in cats. One report can list several signs, so these do not add up to reports. The grouping into body systems is ours; the signs in each group are listed beside it.
Clinical signs reported most
- Hyperactivity2,223 25%
- Lack of efficacy (ectoparasite) - flea1,870 21%
- Panting1,790 20%
- Vocalisation1,254 14%
- Agitation907 10%
- Scratching734 8.4%
- Lethargy567 6.5%
- Pruritus551 6.3%
Reports received per year
Is it approved for cats?
The FDA lists 2 approved animal drug applications containing Nitenpyram for cats, the earliest approved in 2000.
| Product | Form | Approved for | First approved | FDA application |
|---|---|---|---|---|
| CapstarSergeant’s Pet Care Products LLC | Tablet OTC | Cat, Dog | 2000 | 141-175 |
| Program Flavor Tabs And Capstar Flea Management SystemElanco US Inc. | Tablet RX | Cat, Dog | 2003 | 141-205 |
From the FDA record for Capstar: For use in dogs, puppies, cats, and kittens 4 weeks of age and older and 2 pounds of body weight or greater.
What can you do next?
Report counts: FDA Center for Veterinary Medicine adverse event reports, read 11 November 2026 (FDA data last updated 5 October 2026). Approvals: Animal Drugs @ FDA, read 11 November 2026. Counts are reports, not animals and not doses.
Where can you go from this result?
This result is one of 94 in the lookup. See Nitenpyram in dogs (10,786 reports). Open it in the lookup to set it beside another medicine, or read how the counts were collected.
- Cefovecin in cats8,686
- Sarolaner in cats8,530
- Imidacloprid in cats9,231
- Frunevetmab in cats8,036
To report a suspected side effect in your own animal, follow how to report an animal drug side effect to the FDA. The FDA explains what a report can and cannot show in openFDA's guide to reading the results.
Compiled by Vincent Wesley Couey, PetMaxxing Research (ORCID 0009-0005-6869-308X). Sources: openFDA animal and veterinary adverse event interface; Animal Drugs @ FDA.